Asset Details
Do you wish to reserve the book?
Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
Do you wish to request the book?
Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
2022
Overview
Practice effects (PE) defined as an improvement of performance in cognition due to repeated assessments between sessions is well known in unimpaired individuals, while less is known about impaired cognition and particularly in latent brain disease as autosomal-dominant Alzheimer’s disease. The purpose was to evaluate the general (across tests/domains) and domain-specific PE calculated as Annual Rate of Change (ARC) in relation to years to the estimated disease onset (YECO) and in four groups of AD: asymptomatic mutation carriers (aAD, n=19), prodromal, i.e. ,symptomatic mutation carriers, criteria for AD diagnosis not fulfilled (pAD, n=4) and mutation carriers diagnosed with AD (dAD, n=6) as well as mutation non-carriers from the AD families serving as a healthy controlhealthy comparison groups (HC, n=35). Cognition was assessed at baseline and follow-up about three years later by 12 tests covering six domains. The aAD and HC groups were comparable at baseline in demographic characteristics (age, gender, and education), when they were in the early 40ies, while the pAD and dAD groups were older and cognitively impaired. The results on mean ARC for the four groups were significantly different, small, positive, and age-insensitive in the HC group, while ARC was negative and declining with time/disease advancement in AD. The differences between HC and aAD groups in mean ARC and domain-specific ARC were not significant indicating a subtle PE in aAD in the early preclinical stage of AD. In symptomatic stages of AD, there was no PE probably due to cognitive disease-related progression. PE was largest in the verbal domain in both the HC and aAD groups indicating a relationship with cognitive vulnerability. The group-related difference in mean ARC was predominant in timekeeping tests. To conclude, the practice effect in over three years was suggested to be linked to procedural learning and memory/adaption to cognitive demands.
Publisher
Frontiers Research Foundation
Subject
